Oncology Institute (TOI) Short Interest Ratio & Short Volume $0.15 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Oncology Institute Short Interest DataOncology Institute (TOI) has a short interest of 248,000 shares, representing 0.67% of the float (the number of shares available for trading by the public). This marks a -1.51% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 346,024 shares to cover all short positions.Current Short Interest248,000 sharesPrevious Short Interest251,800 sharesChange Vs. Previous Month-1.51%Dollar Volume Sold Short$76,880.00Short Interest Ratio1.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares75,490,000 sharesFloat Size36,770,000 sharesShort Percent of Float0.67%Today's Trading Volume6,972,121 sharesAverage Trading Volume346,024 sharesToday's Volume Vs. Average2,015% Short Selling Oncology Institute? Sign up to receive the latest short interest report for Oncology Institute and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTOI Short Interest Over TimeTOI Days to Cover Over TimeTOI Percentage of Float Shorted Over Time Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Oncology Institute Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024248,000 shares $76,880.00 -1.5%0.7%1.7 $0.31 10/15/2024251,800 shares $80,802.62 -0.3%0.8%2 $0.32 9/30/2024252,500 shares $82,542.25 +8.4%0.8%2 $0.33 9/15/2024233,000 shares $76,703.60 -22.8%0.7%1.8 $0.33 8/31/2024301,700 shares $108,853.36 +25.2%0.9%2.1 $0.36 8/15/2024240,900 shares $86,242.20 +9.6%0.7%1.4 $0.36 Get the Latest News and Ratings for TOI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024219,900 shares $120,065.40 -15.8%0.7%1.3 $0.55 7/15/2024261,000 shares $130,500.00 -13.5%0.8%1.5 $0.50 6/30/2024301,800 shares $138,828.00 +29.8%1.0%1.8 $0.46 6/15/2024232,600 shares $104,670.00 +13.2%0.7%1.3 $0.45 5/31/2024205,500 shares $101,558.10 -5.6%0.7%1.1 $0.49 5/15/2024217,600 shares $148,838.40 -18.9%0.7%1.3 $0.68 4/30/2024268,400 shares $284,504.00 +6.5%0.9%2.2 $1.06 4/15/2024252,000 shares $299,880.00 -4.1%0.8%2.2 $1.19 3/31/2024262,700 shares $415,066.00 +12.1%0.8%2.1 $1.58 3/15/2024234,300 shares $393,624.00 +3.8%0.8%1.7 $1.68 2/29/2024225,700 shares $424,316.00 -7.0%0.7%1.2 $1.88 2/15/2024242,600 shares $434,254.00 -20.8%0.8%1.1 $1.79 1/31/2024306,200 shares $627,710.00 -7.5%1.0%1.1 $2.05 1/15/2024330,900 shares $684,963.00 +20.3%0.8%1.1 $2.07 12/31/2023275,000 shares $561,000.00 +51.3%0.7%0.9 $2.04 12/15/2023181,800 shares $245,430.00 -35.0%0.7%0.6 $1.35 11/30/2023279,800 shares $478,458.00 -37.4%1.1%1 $1.71 11/15/2023447,000 shares $992,340.00 +91.3%1.7%1.8 $2.22 10/31/2023233,700 shares $446,367.00 -4.6%0.9%1 $1.91 10/15/2023245,000 shares $379,750.00 -8.8%0.9%1.2 $1.55 9/30/2023268,500 shares $375,900.00 +6.2%1.0%1 $1.40 9/15/2023252,900 shares $417,285.00 -11.9%1.0%0.9 $1.65 8/31/2023286,900 shares $332,804.00 -17.9%0.9%0.4 $1.16 8/15/2023349,300 shares $299,629.54 +42.0%1.1%0.4 $0.86 7/31/2023246,000 shares $240,440.40 -45.3%0.8%0.3 $0.98 7/15/2023450,000 shares $319,635.00 -7.3%1.4%0.5 $0.71 6/30/2023485,400 shares $267,067.08 -74.3%1.5%0.6 $0.55 6/15/20231,890,000 shares $1.14 million +39.0%6.0%2.4 $0.61 5/31/20231,360,000 shares $581,400.00 +5.4%4.4%2.1 $0.43 5/15/20231,290,000 shares $580,500.00 +1.6%4.1%6.6 $0.45 4/30/20231,270,000 shares $647,700.00 +5.8%4.1%7.4 $0.51 4/15/20231,200,000 shares $716,760.00 +2.6%3.9%6.9 $0.60 3/31/20231,170,000 shares $793,143.00 +13.6%3.8%7.2 $0.68 3/15/20231,030,000 shares $682,066.00 +12.0%3.5%5.7 $0.66Financial Prophecy (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. 2/28/2023919,300 shares $1.30 million -21.4%3.2%6.7 $1.41 2/15/20231,170,000 shares $1.83 million -14.6%4.0%6.9 $1.56 1/31/20231,370,000 shares $2.03 million +31.7%4.7%7.1 $1.48 1/15/20231,040,000 shares $1.77 million +4.0%3.6%5.2 $1.70 12/30/20221,000,000 shares $1.65 million -8.3%3.8%5.1 $1.65 12/15/20221,090,000 shares $1.00 million +39.6%4.2%5.6 $0.92 11/30/2022780,600 shares $1.10 million -17.0%3.0%3.9 $1.41 11/15/2022940,500 shares $1.92 million -3.4%3.6%5.6 $2.04 10/31/2022973,100 shares $4.42 million -8.2%3.7%7 $4.54 10/15/20221,060,000 shares $4.71 million -18.5%4.1%8.4 $4.44 9/30/20221,300,000 shares $6.02 million +46.7%5.1%10.8 $4.63 9/15/2022886,100 shares $4.08 million -6.6%3.5%6 $4.61 8/31/2022948,900 shares $6.03 million +0.0%3.7%7.8 $6.35 8/15/2022948,700 shares $5.87 million +8.1%3.8%7.5 $6.19 7/31/2022878,000 shares $5.67 million -4.3%3.5%6.8 $6.46 7/15/2022917,000 shares $5.36 million +15.0%3.6%6.7 $5.84 6/30/2022797,600 shares $4.04 million +83.2%3.1%5.7 $5.06 6/15/2022435,400 shares $2.79 million -24.7%1.7%3.1 $6.40 5/31/2022578,100 shares $5.21 million +5.2%2.3%5.6 $9.01 5/15/2022549,300 shares $3.36 million -8.6%2.2%4.7 $6.12 4/30/2022600,800 shares $4.72 million +5.0%2.5%5.8 $7.86 4/15/2022572,000 shares $3.95 million +3.2%2.4%6.1 $6.90 3/31/2022554,100 shares $3.95 million +9.0%2.2%5.8 $7.13 3/15/2022508,500 shares $3.48 million -21.6%2.0%4.3 $6.84 2/28/2022648,800 shares $3.48 million +4.9%2.5%5.2 $5.37 2/15/2022618,500 shares $3.90 million 0.0%2.4%4.8 $6.31 1/31/2022618,700 shares $4.00 million +2.3%2.4%4.5 $6.46 1/15/2022605,100 shares $4.74 million +8.7%2.3%3.8 $7.83 12/31/2021556,500 shares $5.43 million No Change2.2%3.6 $9.75 TOI Short Interest - Frequently Asked Questions What is Oncology Institute's current short interest? Short interest is the volume of Oncology Institute shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 248,000 shares of TOI short. 0.67% of Oncology Institute's shares are currently sold short. Learn More on Oncology Institute's current short interest. What is a good short interest ratio for Oncology Institute? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TOI shares currently have a short interest ratio of 2.0. Learn More on Oncology Institute's short interest ratio. What is a good short interest percentage for Oncology Institute? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.67% of Oncology Institute's floating shares are currently sold short. Is Oncology Institute's short interest increasing or decreasing? Oncology Institute saw a decrease in short interest in the month of October. As of October 31st, there was short interest totaling 248,000 shares, a decrease of 1.5% from the previous total of 251,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Oncology Institute's float size? Oncology Institute currently has issued a total of 75,490,000 shares. Some of Oncology Institute's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oncology Institute currently has a public float of 36,770,000 shares. How does Oncology Institute's short interest compare to its competitors? 0.67% of Oncology Institute's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Oncology Institute: Concord Medical Services Holdings Limited (0.48%), OpGen, Inc. (0.19%), Psychemedics Co. (0.31%), BioRestorative Therapies, Inc. (0.87%), Ontrak, Inc. (3.75%), ATI Physical Therapy, Inc. (0.86%), Mangoceuticals, Inc. (15.31%), Agape ATP Co. (7.86%), Kindly MD, Inc. (17.08%), BioNexus Gene Lab Corp. (1.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Oncology Institute stock? Short selling TOI is an investing strategy that aims to generate trading profit from Oncology Institute as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Oncology Institute? A short squeeze for Oncology Institute occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TOI, which in turn drives the price of the stock up even further. How often is Oncology Institute's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TOI, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Concord Medical Services Short Interest OpGen Short Interest Psychemedics Short Interest BioRestorative Therapies Short Interest Ontrak Short Interest ATI Physical Therapy Short Interest Mangoceuticals Short Interest Agape ATP Short Interest Kindly MD Short Interest BioNexus Gene Lab Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TOI) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TOI Stock Alerts